Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.
Makiyama A, Arimizu K, Hirano G, Makiyama C, Matsushita Y, Shirakawa T, Ohmura H, Komoda M, Uchino K, Inadomi K, Arita S, Ariyama H, Kusaba H, Shinohara Y, Kuwayama M, Kajitani T, Oda H, Esaki T, Akashi K, Baba E.
Makiyama A, et al. Among authors: inadomi k.
Gastric Cancer. 2018 May;21(3):464-472. doi: 10.1007/s10120-017-0759-9. Epub 2017 Aug 10.
Gastric Cancer. 2018.
PMID: 28799048